Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard M Gebel

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Transplantation|July 17, 2014
What goes around comes aroundHoward M Gebel
Human Immunology|November 16, 2016
The new KAS: Challenges and opportunitiesHoward M Gebel, Malek Kamoun
Human Immunology|November 16, 2016
The new KAS: It takes a villageHoward M Gebel, Malek Kamoun
Clinical Journal of the American Society of Nephrology : CJASN|October 8, 2020
IgE in Antibody-Mediated Rejection: A Novel Pathogenic Mechanism?Benjamin A Adam, Howard M Gebel
Transplantation|December 22, 2017
Of Cells and Microparticles: Assets and Liabilities of HLA Antibody DetectionRobert S Liwski, Howard M Gebel
Current Opinion in Organ Transplantation|May 29, 2019
A diagnostic 'C' saw: the ups and downs of C1q testingHoward M Gebel, Robert A Bray
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2008
Approaches for transplanting the sensitized patient: biology versus pharmacologyHoward M Gebel, Robert A Bray
Kidney International Reports|May 3, 2021
Hurts So Good: Uncovering the Relationship Between Blood Transfusions and Allograft OutcomeHarold C Sullivan, Howard M Gebel
Nature Clinical Practice. Nephrology|October 15, 2008
Monitoring after renal transplantation: recommendations and caveatsRobert A Bray, Howard M Gebel
Current Opinion in Nephrology and Hypertension|August 20, 2010
The evolution and clinical impact of human leukocyte antigen technologyHoward M Gebel, Robert A Bray
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Transplantation|July 17, 2014
What goes around comes aroundHoward M Gebel
Human Immunology|November 16, 2016
The new KAS: Challenges and opportunitiesHoward M Gebel, Malek Kamoun
Human Immunology|November 16, 2016
The new KAS: It takes a villageHoward M Gebel, Malek Kamoun
Clinical Journal of the American Society of Nephrology : CJASN|October 8, 2020
IgE in Antibody-Mediated Rejection: A Novel Pathogenic Mechanism?Benjamin A Adam, Howard M Gebel
Transplantation|December 22, 2017
Of Cells and Microparticles: Assets and Liabilities of HLA Antibody DetectionRobert S Liwski, Howard M Gebel
Current Opinion in Organ Transplantation|May 29, 2019
A diagnostic 'C' saw: the ups and downs of C1q testingHoward M Gebel, Robert A Bray
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2008
Approaches for transplanting the sensitized patient: biology versus pharmacologyHoward M Gebel, Robert A Bray
Kidney International Reports|May 3, 2021
Hurts So Good: Uncovering the Relationship Between Blood Transfusions and Allograft OutcomeHarold C Sullivan, Howard M Gebel
Nature Clinical Practice. Nephrology|October 15, 2008
Monitoring after renal transplantation: recommendations and caveatsRobert A Bray, Howard M Gebel
Current Opinion in Nephrology and Hypertension|August 20, 2010
The evolution and clinical impact of human leukocyte antigen technologyHoward M Gebel, Robert A Bray
Pageof 9